APPLICATION
ANDA210117
TYPE
ANDA
ORIGINAL APPROVAL
2017-10-12
LATEST ACTION
2025-06-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
ALLOPURINOLPrescription
ALLOPURINOL 300MG · TABLET · ORAL
ALLOPURINOLPrescription
ALLOPURINOL 200MG · TABLET · ORAL
ALLOPURINOLPrescription
ALLOPURINOL 100MG · TABLET · ORAL
Approval history
2025-06-13Manufacturing (CMC) · Supplement 6 · unknownAP
2024-02-05Labeling · Supplement 5 · standardAP
2019-04-23Labeling · Supplement 1 · standardAP
2017-10-12UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.